Avantor, Inc.
$8.5
▲
1.67%
2026-04-21 05:30:00
www.avantorsciences.com
NYQ: AVTR
Explore Avantor, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.76 B
Current Price
$8.5
52W High / Low
$16.17 / $7.26
Stock P/E
—
Book Value
$8.24
Dividend Yield
—
ROCE
5.22%
ROE
-9.2%
Face Value
—
EPS
$-0.78
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13,500
Beta
1
Debt / Equity
74.25
Current Ratio
1.78
Quick Ratio
1.18
Forward P/E
9.28
Price / Sales
0.82
Enterprise Value
$9.15 B
EV / EBITDA
9.38
EV / Revenue
1.4
Rating
Hold
Target Price
$10.77
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
| 2. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 3. | BioLife Solutions, Inc. | $22.19 | — | $1.04 B | — | -4.34% | -3.37% | $29.62 / $17.86 | $7.72 |
| 4. | Ekso Bionics Holdings, Inc. | $11.38 | — | $40.55 M | — | -116.13% | -1.08% | $13.5 / $2.73 | $2.54 |
| 5. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 6. | Sharps Technology, Inc. | $1.84 | — | $73.85 M | — | -452.36% | -2.03% | $18.23 / $1.42 | $15.68 |
| 7. | Alcon Inc. | $77.24 | — | $30.37 B | 0.45% | 4.77% | 4.5% | $81.92 / $56.44 | $45.2 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.66 B | 1.62 B | 1.68 B | 1.58 B | 1.69 B | — |
| Operating Profit | 131.5 M | 136.2 M | 128.8 M | 147.4 M | 191.5 M | — |
| Net Profit | 52.4 M | -711.8 M | 64.7 M | 64.5 M | 500.4 M | — |
| EPS in Rs | 0.08 | -1.05 | 0.1 | 0.1 | 0.74 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 6.55 B | 6.78 B | 6.97 B | 7.51 B |
| Operating Profit | 543.9 M | 638.2 M | 857.2 M | 1.13 B |
| Net Profit | -530.2 M | 711.5 M | 321.1 M | 686.5 M |
| EPS in Rs | -0.78 | 1.05 | 0.47 | 1.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 11.79 B | 12.11 B | 12.97 B | 13.46 B |
| Total Liabilities | 6.23 B | 6.16 B | 7.72 B | 8.61 B |
| Equity | 5.57 B | 5.96 B | 5.25 B | 4.86 B |
| Current Assets | 2.45 B | 2.15 B | 2.38 B | 2.66 B |
| Current Liabilities | 1.38 B | 2.01 B | 1.48 B | 1.66 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 623.8 M | 840.8 M | 870 M | 843.6 M |
| Investing CF | -130.5 M | 438.9 M | -143.7 M | -109.6 M |
| Financing CF | -409.4 M | -1.28 B | -843.7 M | -648.7 M |
| Free CF | 495 M | 692 M | 723.6 M | 710.2 M |
| Capex | -128.8 M | -148.8 M | -146.4 M | -133.4 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -2.64% | -7.26% | — | — |
| Earnings Growth % | 121.58% | -53.23% | — | — |
| Profit Margin % | 10.49% | 4.61% | 9.14% | — |
| Operating Margin % | 9.41% | 12.3% | 15.04% | — |
| Gross Margin % | 33.6% | 33.93% | 34.65% | — |
| EBITDA Margin % | 21.79% | 15.75% | 20.27% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.